Pages without language links

From OncoWiki
Jump to: navigation, search

The following pages do not link to other language versions.

Prefix  

Showing below up to 349 results in range #1 to #349.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. 5-FU + Cisplatin
  2. 5-FU + Cisplatin + Docetaxel
  3. 5-FU + Cisplatin + RT
  4. 5-FU + Cisplatin + RT + Surgery
  5. 5-FU + Cisplatin + Vinblastine + RT + Surgery
  6. 5-FU + LV
  7. 5-FU + LV + Bevacizumab
  8. 5-FU + LV + Irinotecan
  9. 5-FU + LV + Mitomycin + Dipyridamole
  10. 5-FU + LV + RT
  11. 5-FU + RT
  12. 5-FU MitomycinC Radiation Therapy EORTC Regimen
  13. 5-FU MitomycinC Radiation Therapy Wayne State Regimen
  14. A-C-T
  15. ABDIC
  16. ABVD
  17. AC
  18. AD
  19. ADE
  20. ADOC
  21. AI
  22. AIDA-PETHEMA Group
  23. APL4 - ALLG
  24. ASHAP
  25. ATRA plus As203
  26. Acute Lymphoblastic Leukemia, Adult
  27. Acute Lymphoblastic Leukemia, Pediatric
  28. Acute Myeloid Leukemia,Adult
  29. Adrenocortical Carcinoma
  30. Adriamycin + Cisplatin
  31. Adriamycin + Cisplatin + Paclitaxel
  32. Alemtuzumab
  33. Alemtuzumab + Fludarabine
  34. Amrubicin
  35. Anal Carcinoma
  36. Arsenic Trioxide for APML, new cases
  37. Arsenic Trioxide for relapsed APML
  38. Azacitidine
  39. BEAC
  40. BEAM
  41. BEP
  42. BFM- 95 (German Protocol)
  43. BFM B-Cell
  44. BeGeV
  45. Bendamustine
  46. Bendamustine + Rituximab
  47. Bevacizumab
  48. Bevacizumab + Erlotinib
  49. Bevacizumab + IFN
  50. BiRD
  51. Bicalutamide
  52. Bile Duct Cancer Extrahepatic
  53. Bladder Cancer
  54. Bonn protocol
  55. Bortezomib
  56. Brain Tumors Adult
  57. Breast Cancer
  58. Brentuximab vedotin
  59. CAF
  60. CALGB 8811
  61. CALGB 9111
  62. CALGB 9710
  63. CB
  64. CBI
  65. CEOP
  66. CEP
  67. CFAR
  68. CHOEP-14
  69. CHOP
  70. CHOP-14
  71. CIM
  72. CLAG
  73. CLAG-M
  74. CMF
  75. CMV
  76. CNOP
  77. CODOX-M/IVAC
  78. COPP
  79. CVD
  80. CVD + IL-2 + IFN
  81. CVP
  82. Cancer treatment information
  83. CapIri
  84. Capecitabine
  85. Capecitabine + RT
  86. Carboplatin
  87. Carboplatin + Docetaxel
  88. Carboplatin + Etoposide
  89. Carboplatin + Gemcitabine
  90. Carboplatin + Irinotecan
  91. Carboplatin + Paclitaxel
  92. Carboplatin + Paclitaxel + Bevacizumab
  93. Carboplatin + Paclitaxel + Etoposide
  94. Carboplatin + Pemetrexed
  95. Carboplatin + Vinorelbine
  96. Carcinoid Tumors, Gastrointestinal
  97. Carmustine
  98. Cervical Cancer
  99. Cetuximab
  100. Cetuximab + Irinotecan
  101. ChlVPP
  102. Chlorambucil
  103. Chlorambucil + Prednisone
  104. Chronic Lymphocytic Leukemia
  105. Chronic Myelogenous Leukemia
  106. Cisplatin
  107. Cisplatin + 5-FU
  108. Cisplatin + 5-FU + RT
  109. Cisplatin + Capecitabine
  110. Cisplatin + Docetaxel
  111. Cisplatin + Epirubicin
  112. Cisplatin + Epirubicin + 5-FU
  113. Cisplatin + Etoposide
  114. Cisplatin + Etoposide + Bleomycin
  115. Cisplatin + Etoposide + RT
  116. Cisplatin + Etoposide + RT → Docetaxel
  117. Cisplatin + Etoposide or Vinorelbine or Vinblastine or Vindesine
  118. Cisplatin + Gemcitabine
  119. Cisplatin + Gemcitabine + Bevacizumab
  120. Cisplatin + Irinotecan
  121. Cisplatin + Irinotecan + Bevacizumab
  122. Cisplatin + Paclitaxel
  123. Cisplatin + Pemetrexed
  124. Cisplatin + RT
  125. Cisplatin + Topotecan
  126. Cisplatin + Vinorelbine
  127. Cladribine
  128. Clofarabine, cyclophosphamide and etoposide
  129. Colon Cancer
  130. Current events
  131. Cyclophosphamide
  132. Cyclophosphamide Bortezomib Dexamethasone
  133. Cytarabine Idarubicin Vorinostat consolidation
  134. Cytarabine Idarubicin Vorinostat induction
  135. Cytotoxic Regimens
  136. DAT
  137. DHAP
  138. DHAX
  139. DT-PACE
  140. DVD
  141. Dacarbazine
  142. Dacarbazine + Cisplatin + Carmustine
  143. Dactinomycin
  144. Dasatinib
  145. DaunoXome
  146. Decitabine
  147. Dexa-BEAM
  148. Dexamethasone
  149. Dexamethosone
  150. Docetaxel
  151. Docetaxel + Estramustine
  152. Docetaxel + Prednisone
  153. Doxorubicin
  154. Doxorubicin + Bleomycin + Vinblastine
  155. EAPLG
  156. EBVMm
  157. ECF
  158. ECF + surgery + ECF
  159. EP
  160. EPIC
  161. EPOCH
  162. EPOCH-DA
  163. ESHAP
  164. EVA
  165. EVAP
  166. Endometrial Cancer
  167. Erlotinib
  168. Escalated BEACOPP
  169. Esophageal Cancer
  170. Etoposide
  171. Etoposide + Cisplatin
  172. Ewing’s sarcoma and primitive neuroectodermal tumor of bone
  173. FC
  174. FCM
  175. FCR
  176. FLAG
  177. FLAG-Ida
  178. FLOFOXIRI
  179. FLOX
  180. FN
  181. FND
  182. FOLFIRINOX
  183. FOLFIRI + Bevacizumab
  184. FOLFIRI + Cetuximab
  185. FOLFOX
  186. FOLFOX4
  187. FOLFOX4 + Bevacizumab
  188. FOLFOX4 + Cetuximab
  189. FOLFOX6
  190. FOLFOX6 + Bevacizumab
  191. FP + Surgery +/- FP
  192. FUFOX + Cetuximab
  193. Flu Bu ATG - Slavin
  194. Flu Bu ATG for Haplo
  195. Fludarabine
  196. Fludarabine + Prednisone
  197. Fludarabine + Rituximab
  198. Flutamide
  199. Fotemustine
  200. GEM-P
  201. GEM-Vinorelbine-Pred
  202. GVD
  203. Gastric Cancer
  204. Gefitinib
  205. Gemcitabine
  206. Gemcitabine + 5-FU + RT
  207. Gemcitabine + Capecitabine
  208. Gemcitabine + Cisplatin
  209. Gemcitabine + Cisplatin + Paclitaxel
  210. Gemcitabine + Docetaxel
  211. Gemcitabine + Erlotinib
  212. Gemcitabine + Oxaliplatin
  213. Gemcitabine + Paclitaxel
  214. Gemcitabine + Vinorelbine
  215. Gemtuzumab Ozogamicin
  216. Goserelin
  217. Goserelin + Flutamide + RT
  218. Guidelines for contributors
  219. Guidelines on using this site
  220. HAM
  221. Hairy Cell Leukemia
  222. Hematological Malignancies
  223. Hepatocellular Cancer Adult, Primary
  224. High dose Methotrexate
  225. HyperCVAD
  226. HyperCVADHDMTX-AraC
  227. ICE
  228. ICE-aml
  229. IFL + Bevacizumab
  230. IL-2
  231. IMVP-16
  232. IVE
  233. Ifosfamide
  234. Ifosfamide + Paclitaxel
  235. Imatinib
  236. Kaposi's Sarcoma
  237. Ketoconazole
  238. Kidney Renal Cell Cancer
  239. LALA
  240. LV5FU-P
  241. LV + 5-FU + Irinotecan + Bevacizumab
  242. Lenalidomide
  243. Lenalidomide + Rituximab
  244. Linker Regimen
  245. Lung Cancer Non Small Cell
  246. Lung Cancer Small Cell
  247. Luprolide
  248. Lymphoma Hodgkin's, Adult
  249. Lymphoma Non-Hodgkin's, Adult
  250. M-BACOD
  251. MACOP-B
  252. MAID
  253. MCP
  254. MIME
  255. MINE/ESHAP
  256. MOPP
  257. MOPPABV Hybrid
  258. MP
  259. MPT
  260. MRC UKALL XII/ECOG E2993
  261. MVAC
  262. Main Page
  263. Malignant Mesothelioma
  264. Megestrol acetate
  265. Melanoma
  266. MiCMA
  267. Mini-BEAM
  268. Mitoxantrone + Prednisone
  269. Multiple Myeloma And Plasma Cell Dyscrasias
  270. Myelodysplastic Syndromes
  271. Nasopharyngeal Cancer
  272. Nilotinib
  273. Non-Hematological Malignancies
  274. Oblimersen + Dacarbazine
  275. Octreotide
  276. Ovarian Epithelial Cancer
  277. Oxaliplatin + Capecitabine
  278. PAC
  279. PAD
  280. PCR
  281. PCV
  282. Paclitaxel
  283. Paclitaxel + Carboplatin + Gemcitabine
  284. Paclitaxel + Gemcitabine
  285. Paclitaxel IV + Cisplatin IP + Paclitaxel IP
  286. Pancreatic Cancer
  287. Panitumumab
  288. Pegylated liposomal doxorubicin
  289. Pemetrexed
  290. Pentostatin
  291. Plerixafor and G-CSF
  292. Postremission High Dose Cytarabine
  293. Prednisone
  294. Prostate Cancer
  295. R-CHOP
  296. R-CVP
  297. R-EPOCH
  298. R-FCM
  299. R-FCM + maintenance R
  300. R-GemOx
  301. R-MCP
  302. R-MPV
  303. RC
  304. RICE
  305. RTOG study 93-10
  306. Rev/Dex
  307. Rituximab
  308. Rituximab, Bendamustine, Bortezomib
  309. SMILE
  310. Sandbox
  311. Sarcoma
  312. Satraplatin + Prednisone
  313. Sorafenib
  314. Standard3plus7
  315. Standard BEACOPP
  316. Stanford V
  317. Stem Cell Transplantation
  318. Streptozocin + 5-FU
  319. Streptozocin + Doxorubicin
  320. Sunitinib
  321. TIP
  322. Tamoxifen
  323. Temozolomide
  324. Temozolomide + IFN
  325. Temozolomide + IL-2 + IFN + GM-CSF
  326. Temozolomide + RT
  327. Temozolomide + Thalidomide
  328. Temsirolimus
  329. Test spam
  330. Testicular Cancer
  331. Thal/Dex
  332. Thymoma And Thymic Carcinoma
  333. Topotecan
  334. Total Therapy 1
  335. Total Therapy 2
  336. TrophoblasticTumors, Gestational
  337. Unknown Primary, Carcinoma Of
  338. VAD
  339. VDT-PACE
  340. VIP
  341. VMP
  342. VMPT
  343. VNCOP-B
  344. VeIP
  345. Vinorelbine
  346. Vorinostat
  347. Weekly Carboplatin + Paclitaxel + RT → Carboplatin + Paclitaxel
  348. XELIRI + Bevacizumab
  349. XELOX + Bevacizumab

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)